Treatment adherence on methadone maintenance treatment patients Mental and Behavioural Disorders
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Aged 18 years old and over 2. Willing to participate 3. Able to attend the methodone maintenance treatment (MMT) clinics during the study period were recruited from the three MMT clinics.
Exclusion criteria
Exclusion criteria: 1. Unable to communicate because of any health problem that is considered limited, too weak to participate such as a serious illness 2. Serious neurological problems 3. Has been arrested during methodone maintenance treatment (MMT) have violated the law such as gathering to use drugs, illegally trading drugs or disrupting social order and security such as: robbery, murder. There were no links during the initial survey period of more than one week.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Treatment adherence data was measured using data extracted from the dispensing department database and the daily dose management software, and categorized into three groups: complete adherence, consecutive adherence, and weekend adherence at baseline, after 3 months of intervention, after 6 months of intervention | — |
Secondary
| Measure | Time frame |
|---|---|
| The following secondary outcome measures, unless stated, were measured using data extracted from the dispensing department database and the daily dose management software, and categorized into three groups: complete adherence, consecutive adherence, and weekend adherence: 1. Complete adherence, defined as patients adhering fully (100%) without missing any doses over the past three months 2. Consecutive adherence, defined as patients not missing three or more consecutive doses within the past three months 3. Weekend adherence, defined as patients not missing any doses over the past weekend 4. Tobacco addiction measured using the Fagerström Test for Nicotine Dependence (FTND) at baseline, after 3 months of intervention, and after 6 months of intervention 5. Alcohol use measured using the Alcohol Use Disorders Identification Test (AUDIT) at baseline, after 3 months of intervention, and after 6 months of intervention 6. The availability of social support measured using the Medical Outcomes Study – Social Support Survey (MOS-SSS) at baseline, after 3 months of intervention, and after 6 months of intervention 7. Interpersonal trust in patient-physician relationships measured using the Trust in Physician Scale (TPS), where higher scores reflect greater trust Satisfaction and the treatment facility assessed using a 5-point Likert scale at baseline, after 3 months of intervention, and after 6 months of intervention 8. General health status measured using the EuroQol - 5 Dimensions - 5 Levels (EQ-5D-5L) and the EuroQol - Visual Analogue Scale (EQ-VAS) at baseline, after 3 months of intervention, and after 6 months of intervention 9. Comorbidities and ARV treatment measured using data obtained from medical records at one timepoint | — |
Countries
Viet Nam